State of Wyoming’s Standard BioTools LAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.48K Sell
2,694
-342
-11% -$414 ﹤0.01% 1761
2025
Q4
$3.89K Buy
3,036
+98
+3% +$132 ﹤0.01% 1757
2025
Q3
$3.82K Buy
2,938
+155
+6% +$203 ﹤0.01% 1784
2025
Q2
$3.34K Buy
+2,783
New +$3.08K ﹤0.01% 1800
2022
Q3
Sell
-9,928
Closed -$16K 1739
2022
Q2
$16K Buy
9,928
+5,633
+131% +$13.9K 0.01% 1525
2022
Q1
$15K Buy
4,295
+798
+23% +$2.76K 0.01% 1527
2021
Q4
$14K Buy
+3,497
New +$16.4K 0.01% 1617

Other funds holding LAB

State of Wyoming's LAB Position: Q1 2026 in Review

State of Wyoming reduced its Standard BioTools (LAB) stake by 11% in Q1 2026, selling an estimated $414 and leaving 2,694 shares worth $2.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1761.

State of Wyoming first reported a position in LAB in Q4 2021 and has held it in 7 quarters since. The position peaked at $16K in Q2 2022. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

  • State of Wyoming held 2,694 shares of Standard BioTools worth $2.48K as of Q1 2026.
  • State of Wyoming sold 342 Standard BioTools shares in Q1 2026, an estimated $414.
  • Standard BioTools made up ﹤0.01% of State of Wyoming's portfolio in Q1 2026, its #1761 holding.
  • State of Wyoming first reported a position in Standard BioTools in Q4 2021 and has held it in 7 quarters since.
  • State of Wyoming's Standard BioTools position peaked at $16K in Q2 2022.
  • 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on State of Wyoming's 13F filing for Q1 2026, filed 13 May 2026.